Oct 01, 2018 7:30am EDT First Patient Enrolled in Phase 2 Study of Zuclomiphene Citrate for Treatment of Hot Flashes Caused by Androgen Deprivation Therapy
Sep 12, 2018 8:00am EDT Veru has Successful Pre-IND Meeting with FDA for VERU-111 Next Generation Novel Oral Anti-Tubulin Therapy for Metastatic Prostate Cancer
Aug 30, 2018 8:00am EDT Veru to Ring NASDAQ Closing Bell on August 31 to Kick Off National Prostate Cancer Awareness Month
Aug 29, 2018 8:00am EDT Veru Announces Additional Information Regarding its South Africa Female Condom Tender Award